Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Q4 2020 Lantern Pharma Inc. Earnings Call Transcript

Mar 10, 2021 / 09:00PM GMT
Release Date Price: $16.65 (+4.19%)
Operator

Good afternoon, and welcome to Lantern Pharma's Fourth Quarter 2020 Conference Call. As a reminder, this call is being recorded. (Operator Instructions) I would now like to introduce your host for today's conference, Marek Ciszewski, with Investor Relations at Lantern Pharma. Marek, please go ahead.

Marek Ciszewski

Thank you very much, Christy, and thank you for joining us for Lantern Pharma's Fourth Quarter 2020 Conference Call. On the call today are Panna Sharma, Lantern's President and CEO; and David Margrave, Lantern's CFO. A press release was issued this afternoon with our fourth quarter financial results that we will be discussing here today. Following the safe harbor statement, Panna will provide an overview of

(technical difficulty)

after which, David will share our quarterly financial results. Panna will then offer concluding comments, after which we will open this call to questions. Please also note that we have provided our link on our IR website to the slides that we will be referencing in today's call.

I would also like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot